Two lots of the compounding drug called SyrSpend SF Cherry were recently recalled after a “bad smell” alerted someone that the drug might have a possible bacterial contamination.
The drug’s manufacturer, Fagron, issued a nationwide alert on lots numbered A67185 and A67186, both with expiration dates of 8/31/2024. According to the recall, the bacteria is “an opportunistic pathogen most commonly affecting patients with respiratory disease” which could lead to severe consequences. If this sounds like history repeating itself, it is
Most consumers were unaware of just how often compounding drugs are used in hospitals and clinics, particularly in pain management, until the 2012 viral meningitis outbreak caused by contaminated drugs back in 2012. That left numerous people dead, others disabled and many more were exposed and had to undergo invasive testing to make sure they were clear of the disease.
Compounded drugs serve a vital purpose in health care in the U.S., simply because compound pharmacies can provide “made-to-order” drugs that can be tailored around patients with unique sensitivities. More importantly to many providers: Compounded drugs are often cheaper than the alternatives.
However, the oversight on compounding pharmacies isn’t the same as that of a regular retail pharmacy, and that has led to lax safety measures in the past – such as what happened in 2012.
As much as we’d like to believe that modern medicine is safe and secure, mistakes happen all the time. Dangerous and defective drugs make it to market far more often than they should. If you believe that you or a family member has been injured by a defective drug, it may be wise to seek a legal opinion about your options.